Loading data
ACFNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.48 m USD | 10.99 m USD | 8.06 m USD | 7 m USD | 6.78 m USD |
| Cost of revenue | 2.66 m USD | 2.99 m USD | 2.06 m USD | 1.93 m USD | 1.88 m USD |
| Gross profit | 8.82 m USD | 8 m USD | 6 m USD | 5.07 m USD | 4.9 m USD |
| Research and development expense | 1.09 m USD | 1.01 m USD | 875 k USD | 845 k USD | 739 k USD |
| Selling, general and administrative expense | 5.73 m USD | 5.05 m USD | 5.06 m USD | 4.8 m USD | 4.17 m USD |
| Operating profit | 1.99 m USD | 1.94 m USD | 74 k USD | -629 k USD | -8 k USD |
| Profit before tax | 2.11 m USD | 2.01 m USD | 138 k USD | -631 k USD | -13 k USD |
| Income tax expense | -434 k USD | -4.31 m USD | 9 k USD | — | — |
| Net income (reported basis) | 2.51 m USD | 6.29 m USD | 129 k USD | -631 k USD | -21 k USD |
| Basic earnings per share | 1.01 USD/share | 2.53 USD/share | 0.05 USD/share | -0.25 USD/share | 0 USD/share |
| Diluted earnings per share | 0.99 USD/share | 2.51 USD/share | 0.05 USD/share | -0.25 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.